Parithera SA develops circulating tumour cell (CTC) liquid biopsy technologies with single-cell resolution to analyse cancer treatment resistance. The company provides a minimally invasive diagnostic platform that detects and analyses circulating tumour cells to inform clinical decisions on adjusting treatment regimens.
AI-generated
Offering
Products & services
Industry:Software Development
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.